| BIOMARIN PHAR. DL-,001 |
| USA |
| Gesundheit |
| US09061G1013 / 924801 |
| BM8 (Frankfurt) / BMRN (NASDAQ) |
| FRA:BM8, ETR:BM8, BM8:GR, NASDAQ:BMRN |
| - |
| https://www.biomarin.com/ |
|
BioMarin Pharmaceutical Inc. is a leading biotechn..
>Volltext.. |
| 8995.96 Mio. EUR |
| 8300.53 Mio. EUR |
| 2614.84 Mio. EUR |
| 780.7 Mio. EUR |
| 565.2 Mio. EUR |
| 2.96 EUR |
| 526.19 Mio. EUR |
| 1043.83 Mio. EUR |
| 659.39 Mio. EUR |
| 2.09 |
| 6.73% |
| 132.91% |
| - |
| - |
| - |
| - |
| BIOMARIN |
| 28.10.25 |
|